Related Experiment Video
Updated: Jan 22, 2026

Imaging Mismatch Repair and Cellular Responses to DNA Damage in Bacillus subtilis
Published on: February 8, 2010
Mismatch Repair-Proficient Colorectal Cancer: Finding the Right TiME to Respond
Jason A Willis1, Michael J Overman2, Eduardo Vilar3,4,5
1Hematology and Oncology Fellowship Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
New approaches are required for addressing the important and unmet need to expand the benefits of checkpoint blockade to patients with mismatch repair proficient colorectal cancer. Systematic profiling of the tumor immune microenvironment provides insights into potential mechanisms of resistance, predictive biomarkers, and novel combinatorial strategies for overcoming resistance.See related article by Llosa et al., p. 5250.
Insights
New strategies are needed to help more patients with mismatch repair proficient colorectal cancer benefit from checkpoint blockade therapy. Profiling the tumor immune microenvironment can reveal resistance mechanisms and guide new treatments.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Checkpoint blockade immunotherapy has shown promise in cancer treatment.
- However, its benefits are limited in mismatch repair proficient colorectal cancer.
- Novel approaches are crucial to overcome resistance in these patients.
Purpose of the Study:
- To identify new strategies for expanding checkpoint blockade benefits.
- To investigate mechanisms of resistance in mismatch repair proficient colorectal cancer.
- To discover predictive biomarkers and combinatorial treatments.
Main Methods:
- Systematic profiling of the tumor immune microenvironment.
- Analysis of patient data and tumor characteristics.
Main Results:
- Insights into potential mechanisms of resistance were gained.
- Potential predictive biomarkers were identified.
- Novel combinatorial strategies for overcoming resistance were proposed.
Conclusions:
- Understanding the tumor immune microenvironment is key to improving immunotherapy efficacy.
- Targeted approaches are needed to enhance checkpoint blockade in colorectal cancer.
- Further research can lead to expanded treatment options for patients.
Related Concept Videos
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Finding the Center of Gravity

